MyFinsight
Home
About
Contact
onc: the income statement
Download
Download image
Collaboration Other
$987K
Novartis Broad Markets
Revenue
$4,115K
Amgen Royalty Revenue
$12,169K
Other
$20,112K
POBEVCY
$10,499K
KYPROLIS
$18,369K
BLINCYTO
$30,476K
Xgeva
$84,243K
Tevimbra
$190,623K
Brukinsa
$1,040,691K
Other Revenue
$17,271K
Product
$1,395,013K
Total revenues
$1,412,284K
Gross profit
$1,215,774K
Cost of sales -
product-Product
$196,510K
Interest income, net
$3,029K
Income (loss) from
operations
$163,114K
Total operating
expenses
$1,052,660K
Income (loss) before
income taxes
$147,164K
Other (expense)
income, net
-$18,979K
Selling, general and
administrative
$528,998K
Research and development
$523,662K
Net income (loss)
$124,841K
Income tax expense
$22,323K
Back
Back
Income Statement
source: myfinsight.com
BeOne Medicines Ltd. (ONC)
BeOne Medicines Ltd. (ONC)